Another study further pointed out that Nrf2 is a negative regulator of ferroptosis, and that the ferroptosis inducer erastin can inhibit the degradation of Nrf2 by regulating the p62-Keap1-NRF2 signal pathway, thereby inhibiting the occurrence of ferroptosis in hepatoma cells (77). Here, NFE2L2 is linked to hepatocellular carcinoma.